Atlas Trials

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

Clinical trial NCT00191074 · COMPLETED

Trial details

NCT number
NCT00191074
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Growth Disorder
Start date
2001-02-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.